Second-line treatment options in advanced non-small cell lung cancer

Eur J Cancer. 2011 Sep:47 Suppl 3:S258-71. doi: 10.1016/S0959-8049(11)70172-1.
No abstract available

Publication types

  • Evaluation Study
  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Chemotherapy, Adjuvant / adverse effects
  • Chemotherapy, Adjuvant / methods
  • Chemotherapy, Adjuvant / statistics & numerical data
  • Choice Behavior
  • Disease Progression
  • Humans
  • Lung Neoplasms / therapy*

Substances

  • Antineoplastic Agents